Be sure to attend this year’s Plenary Session at the ATS 2025 International Conference in San Francisco on Tuesday, May 20. This cornerstone event embodies the spirit of innovation, collaboration, and patient-centered care, uniting the global respiratory community to spotlight the stories shaping the future of respiratory medicine. This year, we are honored to welcome Len Geiger, a dynamic advocate, speaker, and double lung transplant recipient, as our speaker.
Diagnosed with Alpha-1 antitrypsin deficiency in 1994, Len has turned his personal health journey into a mission to educate, inspire, and drive meaningful change. His experience as a lung transplant recipient in 2002 ignited a passion for raising awareness about Alpha-1 and promoting the transformative impact of organ donation. Over the past two decades, Len has emerged as a national voice for rare disease advocacy, connecting with audiences across the country through media campaigns, educational initiatives, and powerful keynote presentations.
As a Practice Development Specialist at Evexias Health Solutions, Len works with health care providers to implement cutting-edge bioidentical hormone replacement therapies while continuing to champion patient engagement and education. At ATS 2025, he will share his compelling story of resilience, hope, and the profound connections that can transform the lives of patients and their care teams.
Len’s address will challenge us to think deeply about how the medical community can foster greater collaboration, empathy, and innovation to meet the complex needs of patients worldwide. Whether you’re a clinician, researcher, or patient advocate, his message will leave you energized and empowered to make a difference.
The Plenary Session is open to all registered attendees and will also include the ratification of the 2025-2026 slate of leaders, as well as remarks from outgoing president Irina Petrache, MD, ATSF, and incoming president Raed A. Dweik, MD, MBA, ATSF. In addition, the following awards will be presented:
- Outstanding Educator Award
- Research Innovation & Translation Award
- Outstanding Clinician Award
- Philip Hopewell Prize for Leaders in Global Respiratory Health
The ATS thanks GSK for its support of the ATS 2025 Plenary Session.
